Company / Shareholders' Equity
Yubo International Biotech Ltd Shareholders' Equity History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$2.0M
FY2025
5-year range
-$3.4M / $1.2M
FY2021-FY2025
Trend
+42.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Yubo International Biotech Ltd reports negative total equity of -$2M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$2M in FY2025.
Declined from -$2M to -$2M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity increased 42.9% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.0M | +42.9% |
| FY2024 | -$3.4M | -85.7% |
| FY2023 | -$1.8M | -226.1% |
| FY2022 | -$565.4K | -148.4% |
| FY2020 | $1.2M | +138.9% |
| FY2019 | $488.7K | +132.2% |
| FY2018 | -$1.5M | -10.5% |
| FY2017 | -$1.4M | -9.1% |
| FY2016 | -$1.3M | -11.5% |
| FY2015 | -$1.1M | -56.9% |